Register
|
Login
The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
NEWS
CONFERENCES
VIDEOS
Case-Based Peer Perspectives
Expert Perspective Virtual Tumor Board
Interviews
Investigator Perspectives
Precision Medicine
PUBLICATIONS
Evolving Paradigms
Targeted Therapies in Oncology
The Journal of Targeted Therapies in Cancer
ONCAlert | Upfront Therapy for mRCC
Case Studies
Expert physicians provide insight on managing oncology-based patient cases that highlight the use of novel agents in clinical practice.
SORT BY:
A-Z
Recent
VIEW AS:
Grid
List
Prostate Cancer (11)
Follicular Lymphoma (8)
Myeloproliferative Neoplasms (14)
Chronic Lymphocytic Leukemia (12)
Breast Cancer (15)
Multiple Myeloma (12)
Gynecologic Cancer (9)
Colorectal Cancer (20)
Lung Cancer (34)
Hodgkins Lymphoma (3)
Hepatocellular Carcinoma (9)
non-Hodgkins Lymphoma (2)
Cutaneous Squamous Cell Carcinoma (2)
Gastrointestinal Cancer (2)
Marginal Zone Lymphoma (2)
Renal Cell Cancer (6)
Acute Myeloid Leukemia (4)
Pancreatic Cancer (5)
Idiopathic Thrombocytopenic Purpura (1)
Chronic Myeloid Leukemia (2)
Mantle Cell Lymphoma (2)
Gastrointestinal Stromal Tumors (2)
Melanoma (4)
Soft Tissue Sarcoma (3)
Multicentric Castleman Disease (4)
JTT Articles
Participating Practices Commend CMS for OCM Changes
The Role of Liquid Biopsy in NSCLC Continues to Emerge
Rare Incidence of ICI-Related Hepatotoxicity Frequently Ends in Treatment Discontinuation
>> View Peer-Reviewed Articles
Most Popular
Case 1: Immunotherapy in Locally Advanced NSCLC
Becerra Shares Treatment Considerations in 2 Gastrointestinal Case Studies
Brentuximab Vedotin Submitted for FDA Approval as Treatment for Hodgkin Lymphoma
Flinn Analyzes Data from 5-Year Follow-Up of Phase III BRIGHT Trial in Frontline MCL
Publications
